Range
27.56 - 29.59
Vol / Avg.
349K/583.4K
Div / Yield
-
52 Wk
7.35 - 33.24
Mkt Cap
1.1B
Payout Ratio
-
Open
29.24
P/E
-
EPS
-0.42
Shares
39.6M
Outstanding
39.6M
Total Float
39.4M
Benzinga - Jun 4, 2021, 9:17AM
Benzinga - Jun 1, 2021, 7:33AM
Benzinga - May 6, 2021, 4:38PM
Benzinga - Apr 12, 2021, 4:01PM
Benzinga - Mar 30, 2021, 9:00AM
Benzinga - Mar 29, 2021, 4:03PM
Benzinga - Mar 29, 2021, 4:02PM
Benzinga - Mar 29, 2021, 12:17PM
Benzinga - Mar 29, 2021, 7:35AM
Benzinga - Mar 29, 2021, 6:32AM
Benzinga - Feb 23, 2021, 7:06AM
Benzinga - Feb 23, 2021, 6:01AM
Benzinga - Feb 22, 2021, 4:09PM
load more
Sector: Health Care.Industry: Biotechnology
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.380-0.420 -0.0400
REV685.000K685.000K0
Q4 2020Est.ActualSurprise
EPS-0.550
REV3.786M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CLDXCelldex Therapeutics0%1.1B

Celldex Therapeutics Frequently Asked Questions

Q

How do I buy Celldex Therapeutics (CLDX) stock?

A

You can purchase shares of Celldex Therapeutics (NASDAQ: CLDX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Celldex Therapeutics's (CLDX) competitors?

A

Other companies in Celldex Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Immunovant (NASDAQ:IMVT), Humanigen (NASDAQ:HGEN), Mesoblast (NASDAQ:MESO) and Vaxcyte (NASDAQ:PCVX).

Q

What is the target price for Celldex Therapeutics (CLDX) stock?

A

The latest price target for Celldex Therapeutics (NASDAQ: CLDX) was reported by HC Wainwright & Co. on February 23, 2021. The analyst firm set a price target for 36.00 expecting CLDX to rise to within 12 months (a possible 29.54% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Celldex Therapeutics (CLDX)?

A

The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $27.79 last updated Today at 8:00:03 PM.

Q

Does Celldex Therapeutics (CLDX) pay a dividend?

A

There are no upcoming dividends for Celldex Therapeutics.

Q

When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?

A
Celldex Therapeutics’s Q2 earnings are confirmed for after-market on August 5, 2021.
Q

Is Celldex Therapeutics (CLDX) going to split?

A

There is no upcoming split for Celldex Therapeutics.

Q

What sector and industry does Celldex Therapeutics (CLDX) operate in?

A

Celldex Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.